These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3632915)

  • 1. Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes.
    Blomgren H; Blom U; Ulén H
    Cancer Immunol Immunother; 1986; 21(1):31-8. PubMed ID: 3632915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
    Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
    Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
    Blomgren H; Blom U; Ullén H
    Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
    McVicar DW; Davis DF; Merchant RE
    J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of prostaglandin producing monocytes in the depression of mitogenic responses of blood lymphocytes following radiation therapy.
    Blomgren H; Wasserman J; Rotstein S; Petrini B; Baral E
    Radiother Oncol; 1984 Jan; 1(3):255-61. PubMed ID: 6095371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors.
    Roszman TL; Brooks WH; Elliott LH
    Cancer; 1982 Oct; 50(7):1273-9. PubMed ID: 6213292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.
    Roszman TL; Brooks WH
    Clin Exp Immunol; 1980 Feb; 39(2):395-402. PubMed ID: 6966992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma.
    Uh S; Lee SM; Kim HT; Chung Y; Kim YH; Park C; Huh SJ; Lee HB
    Chest; 1994 Jan; 105(1):132-7. PubMed ID: 7903922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiation therapy compared with cyclic chemotherapy in patients with mammary carcinoma. II. Changes of mitogen responses of blood lymphocytes.
    Strender LE; Blomgren H; Wasserman J; Petrini B; Baral E
    Acta Radiol Oncol; 1981; 20(5):299-304. PubMed ID: 6278848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restimulation of PPD-stimulated lymphocytes: decreased responsiveness of prestimulated cells to a second challenge with PPD and PHA.
    Sörén L; Maller R
    Scand J Immunol; 1979; 9(1):1-7. PubMed ID: 311074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer activity of blood lymphocytes in patients with primary intracranial tumors. Correlation to histological tumor type and anatomical site.
    Ullén H; Blom U; Blomgren H
    Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1239-45. PubMed ID: 3816915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of N-acetyl-D-glucosamine (NAG) on mitogenic, antigenic and allogeneic stimulation of normal human lymphocytes.
    Komlos L; Ben-Efraim S; Lewis NJ; Hart J; Halbrecht I
    Int J Immunopharmacol; 1984; 6(6):593-9. PubMed ID: 6239831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meal induced increase in serum triglycerides has no effect on lymphocyte response to mitogens.
    Soppi E; Viikari J; Eskola J; Ruuskanen O
    Eur J Clin Invest; 1979 Aug; 9(4):281-3. PubMed ID: 230059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of PPD-stimulated lymphocytes measured by sister chromatoid differential staining.
    Crossen PE; Morgan WF
    Clin Exp Immunol; 1981 Sep; 45(3):642-5. PubMed ID: 6175457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
    Neuwelt EA; Kikuchi K; Hill S; Lipsky P; Frenkel EP
    Cancer; 1983 Jan; 51(2):248-55. PubMed ID: 6821814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of impaired mitogen responses in autologous whole blood of cancer patients using an optimized method of lymphocyte stimulation.
    Fritze D; Dystant P
    Immunol Lett; 1984; 8(5):243-7. PubMed ID: 6519681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in normal pregnancy and pre-eclampsia.
    Alanen A; Lassila O
    J Reprod Immunol; 1982 Dec; 4(6):349-54. PubMed ID: 7153978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of corticosteroid on lymphocyte responsiveness in pigeon breeder's lung.
    Toogood JH; Khan RH; Baskerville JC; Jennings BH
    Clin Allergy; 1980 Sep; 10(5):547-53. PubMed ID: 7438415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.